Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with ...
GlobalData on MSN5d
Celltrion’s Avtozma receives FDA approval for multiple conditionsThe FDA's approval is grounded in an evidence totality and comprehensive data package, which includes outcomes from a study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback